Oragenics Inc. (LSE:0A64) Financings

Oragenics Inc.

Financings

RaiseDate
Public offering of series H Convertible Preferred Stock and Warrants
Closed: US$16.5M raised · US$25 a share · 1 warrant at US$25 for 60 months · Dawson James Securities, Inc.
Dealers: Dawson James Securities, Inc. (lead)
Use of proceeds: Clinical development of ONP-002, other R&D, repay a $3 million bridge note, working capital and general corporate purposes
Jul 2, 2025

Read by 6ix AI from the company's releases